Gastrointestinal Diseases: Clinical Trials

587 trials for Gastrointestinal Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

587 completed. 587 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4587Completed 587

Follow Gastrointestinal Diseases: new trials by email Literature Review of Gastrointestinal Diseases trials Research Report on Gastrointestinal Diseases

Trials (filtered) newest first · largest first

All 587 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication
vonoprazan-based triple therapy (VAL regimen), Esomeprazole-based triple therapy (EAL regimen) - Helicobacter Pylori Infection, Dyspepsia
Phase 4CompletedBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh802026-04-152026-10-26
Effect of Ondansetron on Patient Tolerance, Efficacy and Endoscopist Workload in Unsedated Endoscopy for Upper Gastrointestinal Bleeding
intravenous ondansetron, Placebo - Esophagogastroduodenoscopy, Upper Gastrointestinal Bleeding (UGIB)
Phase 4CompletedPeking Union Medical College Hospital802026-02-162026-09-16
Efficacy and Safety of GTN vs. Nifedipine in Acute Anal Fissure: A Clinical Trial
Glyceryl Trinitrate (GTN) 0.2% Ointment, Glyceryl Trinitrate (GTN) 0.4% Ointment, Nifedipine 0.2% Ointment - Acute Anal Fissure, Anal Pain
Phase 4CompletedHafiz Muhammad Hamza1102025-03-172025-05-14
Evaluation of the Effectiveness of a Topical Medical Device in Wound Healing and Symptom Relief in the Postoperative Period of Open Excisional Hemorrhoidectomy (The Emor Study)
Gel containing a Propionibacterium extract, Hyaluronic acid and silver sulfadiazine - Anus Diseases, Gastrointestinal Diseases
Phase 4CompletedUniversity of Cagliari1142025-03-042025-07-02
Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2
PYTEST® 14C-Urea Capsule Breath Test (at Home), PYTEST® 14C-Urea Capsule Breath Test (Standard Retesting In-Person) - H. Pylori Infection, Gastric Cancer
Phase 4CompletedUniversity of Miami502024-11-062026-10-16
Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome
Skal Pro, Placebo - Irritable Bowel Syndrome, Gastrointestinal Diseases
Phase 4CompletedEP Plus Group Sdn Bhd572024-10-172026-09-11
Therapeutic Effect of Vonoprazan Versus Dexlansoprazole in Treatment of Gastroesophageal Reflux Disease
Dexlansoprazole 60 mg, Vonoprazan 20 mg bid - Vonoprazan, Proton Pump Inhibitor
Phase 4CompletedAyman Magd Eldin Mohammad Sadek1362024-10-012025-02-27
Evaluation the of Role of Vitamin D Supplement on Tumor Response, Inflammation and Apoptosis in Patients With Stage II or III Colorectal Cancer Receiving Chemotherapy.
Vitamin D - Vitamin D on Tumor Response and Inflammatory Markers, Colo-rectal Cancer
Phase 4CompletedTanta University442024-07-312025-11-21
Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
GLP-1 medication - Diabetes Mellitus, Type 2, Obesity
Phase 4CompletedThe Cleveland Clinic692024-07-312025-12-05
Association Between Effectiveness of Mirikizumab and UC Patients With High Neutrophilic Infiltration in Epithelium of the Colonic Mucosa
Mirikizumab, Vedolizumab - Ulcerative Colitis
Phase 4CompletedShowa Inan General Hospital1002024-07-202025-10-20
Bowel Preparation in Colonoscopy: Lactulose vs Polyethyleneglycol, Randomized Double-blind Comparative Clinical Trial, Multicenter Study.
Bowel preparation before colonoscopy - Colorectal Cancer Screening
Phase 4CompletedHospital Civil de Guadalajara4492024-07-202026-07-28
Effect of Bioflor on Gut Microbiota in Proton-Pump Inhibitor Users
Saccharomyces Boulardii 250 MG, Proton Pump Inhibitors (PPI) - Dysbiosis, Gastroesophageal Reflux Disease (GERD)
Phase 4CompletedSeoul National University Hospital802024-07-182026-10-01
A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease
Breast Milk Sampling, Risankizumab - Inflammatory Bowel Disease
Phase 4CompletedAbbVie102024-04-242026-04-20
Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection
Neostigmine Injectable Solution, Sugammadex injection - Intestinal Disease
Phase 4CompletedUniversity of California, Irvine1322024-04-172026-08-25
Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation
Tenapanor - IBS, IBS - Irritable Bowel Syndrome
Phase 4CompletedKyle Staller, MD, MPH362024-02-062026-03-12
Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer
Pentoxifylline, FOLFOX, XELOX - Metastatic Colorectal Carcinoma
Phase 4CompletedTanta University442024-02-012026-10-21
The Impact of Sugammadex on Ileus After Abdominal Wall Reconstruction
Neostigmine / Glycopyrrolate, Sugammadex - Hernia, Ventral, Ileus
Phase 4CompletedClayton Petro1842024-01-152025-11-21
Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis
Triple Therapy, Quadruple Therapy - Helicobacter Pylori Infection, Chronic Gastritis
Phase 4CompletedAzfar Farogh7522024-01-052025-12-31
Comparison of Probiotic Effects on the Outcomes of Patients After Colorectal Cancer Surgery
Lactobacillus casei Shirota, Lactobacillus acidophilus - Colorectal Cancer
Phase 4CompletedDharmais National Cancer Center Hospital902024-01-012025-08-27
Randomized Control Trial of Micronized Purified Flavonoid Fraction for Post Operative Treatment in Anal Fistula Surgery
Micronized purified flavonoid fraction(Daflon 1000mg), Placebo - Anal Fistula
Phase 4CompletedTaipei Medical University Shuang Ho Hospital1062023-12-132025-05-16

Showing 20 of 587. Sign in to see all of them.

Narrower conditions

Gastroesophageal Reflux (70)  ·  Crohn Disease (63)  ·  Colitis, Ulcerative (56)  ·  Colorectal Neoplasms (53)  ·  Inflammatory Bowel Diseases (40)  ·  Irritable Bowel Syndrome (38)  ·  Stomach Neoplasms (26)  ·  Peptic Ulcer (25)  ·  Colonic Neoplasms (23)  ·  Gastrointestinal Hemorrhage (23)  ·  Appendicitis (19)  ·  Diarrhea (17)  ·  Heartburn (14)  ·  Dyspepsia (13)  ·  Gastritis (13)

Broader conditions

Digestive System Diseases (583)  ·  Intestinal Diseases (362)  ·  Gastroenteritis (192)  ·  Pathological Conditions, Signs and Symptoms (175)  ·  Colonic Diseases (167)  ·  Neoplasms (133)  ·  Esophageal Diseases (126)  ·  Neoplasms by Site (125)  ·  Digestive System Neoplasms (124)  ·  Gastrointestinal Neoplasms (119)  ·  Pathologic Processes (94)  ·  Signs and Symptoms (91)  ·  Rectal Diseases (84)  ·  Inflammatory Bowel Diseases (79)

Interventions

Esomeprazole (47)  ·  Infliximab (20)  ·  Lansoprazole (18)  ·  Omeprazole (17)  ·  Rabeprazole (17)  ·  Amoxicillin (16)  ·  Metronidazole (15)  ·  vedolizumab (15)  ·  Pantoprazole (12)  ·  Bismuth (10)  ·  Clarithromycin (10)  ·  Mesalamine (10)  ·  Adalimumab (9)  ·  Sodium Chloride (9)  ·  Capecitabine (8)

Sponsors

AstraZeneca (27)  ·  Takeda (14)  ·  Xijing Hospital of Digestive Diseases (10)  ·  Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives (9)  ·  Hoffmann-La Roche (7)  ·  Mayo Clinic (7)  ·  Universitaire Ziekenhuizen KU Leuven (7)  ·  Chinese University of Hong Kong (6)  ·  Kaohsiung Veterans General Hospital. (6)  ·  Novartis Pharmaceuticals (5)  ·  GlaxoSmithKline (4)  ·  Herlev Hospital (4)  ·  Medical University of Warsaw (4)  ·  Region Örebro County (4)  ·  Yonsei University (4)

Countries

United States (144)  ·  China (50)  ·  France (40)  ·  South Korea (33)  ·  Italy (31)  ·  Canada (29)  ·  Denmark (29)  ·  Spain (25)  ·  Taiwan (25)  ·  Belgium (24)  ·  United Kingdom (24)  ·  Netherlands (23)  ·  Germany (18)  ·  Poland (15)  ·  Sweden (14)

Top investigators

Paula Fernstrom (8)  ·  Arie Levine, MD (4)  ·  Yongquan Shi, Ph. D (4)  ·  Andrew J Clarke, PhD (2)  ·  Arnulf Ferlitsch, MD (2)  ·  Ayman Sadek, MD (2)  ·  Bor-Shyang Sheu, MD (2)  ·  Brian G Feagan, MD (2)

Results publications

PMID 25478944, PMID 40013523, PMID 10343249, PMID 10395629, PMID 10403850, PMID 10536559, PMID 10896917, PMID 11156645, PMID 11256129, PMID 11822956, PMID 11857360, PMID 12127688, PMID 12170403, PMID 12432298, PMID 1305308, PMID 14570648, PMID 14644354, PMID 14762782, PMID 1479177, PMID 1499440, PMID 15044883, PMID 15058524, PMID 15094271, PMID 15168373, PMID 15488052, PMID 15519198, PMID 15555725, PMID 15645403, PMID 15738894, PMID 15793647, PMID 15818423, PMID 15838899, PMID 15843939, PMID 15888773, PMID 15901026, PMID 15915027, PMID 16116317, PMID 16266222, PMID 16279893, PMID 16393226, PMID 16393228, PMID 16500392, PMID 16611269, PMID 16612915, PMID 1669678, PMID 16882832, PMID 16927929, PMID 16937471, PMID 17058158, PMID 17058159

NIH funding

2014 (9), 2015 (4), 2008 (3), 2009 (3), 2017 (3), 2019 (2), 2005 (1), 2016 (1), 2018 (1), K23DK115827 (1), K23DK124567 (1), K24DK078228 (1), R01CA091912 (1), R01DK059961 (1), R01DK101856 (1)